SMS Pharmaceuticals to hold 38th AGM on Sept 29, 2026
SMS Pharmaceuticals Limited will hold its 38th Annual General Meeting on September 29, 2026, via video conference. The record date for dividend and e-voting eligibility is September 22, 2026. Remote e-voting will be open from September 25 to September 28, 2026.
This is a routine corporate event and does not directly impact the company's financial performance or operations in the short term.
The announcement is a routine corporate communication regarding the Annual General Meeting and associated dates, with no significant positive or negative financial or operational news.
SMS Pharmaceuticals Limited has announced that its 38th Annual General Meeting (AGM) will be held on Tuesday, September 29, 2026, at 10:30 a.m. IST through Video Conferencing (VC) or Other Audio-Visual Means. The company will also dispatch the Notice convening the 38th AGM along with the Annual Report for the financial year 2025-26 to its members. The Annual Report is also available on the company's website. Members will have the facility to exercise their right to vote on the proposed resolutions by electronic means. The Record Date for Dividend and cut-off date for e-voting eligibility and attending the AGM is Tuesday, September 22, 2026. Book Closure Dates are from Wednesday, September 23, 2026, to Tuesday, September 29, 2026, inclusive. Remote e-voting will commence on Friday, September 25, 2026, at 9:00 a.m. IST and end on Monday, September 28, 2026, at 5:00 p.m. IST.
What to do with a filing like this
SMS Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by SMS Pharmaceuticals Limited. Read the original for the full detail.